These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6970626)

  • 1. Human-B and T-lymphocyte locomotion in response to casein, C5a, and f-met-leu-phe.
    El-Naggar AK; Van Epps DE; Williams RC
    Cell Immunol; 1980 Dec; 56(2):365-73. PubMed ID: 6970626
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of culturing on the human lymphocyte locomotion response to casein, C5a, and fMet-Leu-Phe.
    El-Naggar A; Van Epps DE; Williams RC
    Cell Immunol; 1981 May; 60(1):43-9. PubMed ID: 7237565
    [No Abstract]   [Full Text] [Related]  

  • 3. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucoattractants enhance complement receptors on human phagocytic cells.
    Kay AB; Glass EJ; Salter DM
    Clin Exp Immunol; 1979 Nov; 38(2):294-9. PubMed ID: 527263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
    Gnessi L; Ruff MR; Fraioli F; Pert CB
    Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of lymphocyte locomotion in immunodeficiency disease.
    Van Epps DE; El-Naggar A; Ochs HD
    Clin Exp Immunol; 1983 Sep; 53(3):679-88. PubMed ID: 6616960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formyl peptide chemoattractants. Synthesis and chemotactic activity.
    Falcomer C; Vertuani G; Boggian M; Scatturin A; Spisani S; Cavalletti T; Traniello S
    Farmaco Sci; 1987 Nov; 42(11):815-22. PubMed ID: 3443176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators and modulators of human lymphocyte chemotaxis.
    van Epps DE
    Agents Actions Suppl; 1983; 12():217-33. PubMed ID: 6220584
    [No Abstract]   [Full Text] [Related]  

  • 12. Pepstatin A--a human leukocyte chemoattractant.
    Ackerman SK; Douglas SD
    Clin Immunol Immunopathol; 1979 Oct; 14(2):244-50. PubMed ID: 487669
    [No Abstract]   [Full Text] [Related]  

  • 13. Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.
    Marceau F; deBlois D; Laplante C; Petitclerc E; Pelletier G; Grose JH; Hugli TE
    Circ Res; 1990 Nov; 67(5):1059-70. PubMed ID: 1699682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis.
    Schröder JM; Christophers E
    Immunobiology; 1983 Mar; 164(2):127-35. PubMed ID: 6852861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte chemotactic activity of human interleukin 1.
    Miossec P; Yu CL; Ziff M
    J Immunol; 1984 Oct; 133(4):2007-11. PubMed ID: 6332145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired motility of neonatal PMN leukocytes: relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients.
    Anderson DC; Hughes BJ; Wible LJ; Perry GJ; Smith CW; Brinkley BR
    J Leukoc Biol; 1984 Jul; 36(1):1-15. PubMed ID: 6376671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic activities of avian lymphocytes.
    Lam KM
    Dev Comp Immunol; 1999; 23(7-8):641-7. PubMed ID: 10579392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants.
    Glass EJ; Kay AB
    Clin Exp Immunol; 1980 Mar; 39(3):768-75. PubMed ID: 7379336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of locomotion in human T cell subsets.
    Parrott DM; Good RA; O'Neill GJ; Gupta S
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2392-5. PubMed ID: 307761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
    Matzner Y; Marx G; Drexler R; Eldor A
    Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.